More is better: A multimodality approach to cancer cachexia

Oncologist

Volumn 15, Issue 2, 2010, Pages 119-121

  Del Fabbro, Egidio ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DRONABINOL; ETANERCEPT; FISH OIL; GESTAGEN; INFLIXIMAB; INTERLEUKIN 6; MEGESTROL ACETATE; THALIDOMIDE;

ADIPOSE TISSUE; ADVANCED CANCER; ANOREXIA; ANTINEOPLASTIC ACTIVITY; APPETITE; BODY COMPOSITION; CACHEXIA; CALORIC INTAKE; CANCER CACHEXIA; CATABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; COUNSELING; DOCTOR PATIENT RELATION; DOSE RESPONSE; DYSGEUSIA; EDITORIAL; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; EXERCISE; FATIGUE; FOOD AVERSION; HOME MONITORING; HUMAN; HYPOGONADISM; LEAN BODY WEIGHT; MONOTHERAPY; MUSCLE ATROPHY; NAUSEA; NUTRITION; NUTRITIONAL STATUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SATIETY; THROMBOEMBOLISM; TREATMENT DURATION; WEIGHT GAIN; WEIGHT REDUCTION;

CACHEXIA; HUMANS; NEOPLASMS; QUALITY OF LIFE;

EID: 77649154737     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0019     Document Type: Editorial

References (16)

1. Jatoi A, Dakhil SR, Nguyen PL et al. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: Results from N00C1 from the North Central Cancer Treatment Group. Cancer 2007;110:1396-1403.
2. Wiedenmann B, Malfertheiner P, Friess H et al. A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol 2008;6:18-25.
3. Jatoi A, Rowland K, Loprinzi CL et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004;22: 2469-2476.
4. Jatoi A, Windschitl HE, Loprinzi CL et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A North Central Cancer Treatment Group study. J Clin Oncol 2002;20:567-573.
5. Mantovani G, Macciò A, Madeddu C at al. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. The Oncologist 2010;15:200-211.
6. Evans WJ, Morley JE, Argilés J et al. Cachexia:Anew definition. Clin Nutr 2008;27:793-799.
7. Bozzetti F, Mariani L. Defining and classifying cancer cachexia: A proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr 2009; 33:361-367.
8. Tan BH, Birdsell LA, Martin L et al. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009;15):6973-6979.
9. Prado CM, Baracos VE, McCargar LJ et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009;15: 2920-2926.
10. Dev R, Del Fabbro E, Bruera E. Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer. Cancer 2007;110:1173-1177.
11. Lundholm K, Körner U, Gunnebo L et al. Insulin treatment in cancer cachexia: Effects on survival, metabolism, and physical functioning. Clin Cancer Res 2007;13:2699-2706.
12. Cerchietti LC, Navigante AH, Peluffo GD et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: A pilot study. J Pain Symptom Manage 2004;27:85-95.
13. Del Fabbro E, Dalal S, DelgadoMet al. Secondary versus primary cachexia in patients with advanced cancer. J Clin Oncol 2007;25(suppl 18):9128.
14. Yavuzsen T, Walsh D, Davis MP et al. Components of the anorexia-cachexia syndrome: Gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 2009;17:1531-1541.
15. Minton O, Richardson A, Sharpe M et al. A systematic review and metaanalysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst 2008;100:1155-1166.
16. Tan BH, Deans DA, Skipworth RJ et al. Biomarkers for cancer cachexia: Is there also a genetic component to cachexia? Support Care Cancer 2008;16: 229-234.